drugset / Trial / NCT03239158
Bioinformation Therapy for Liver Cancer
Phase 2/3
Completed
120 enrolled
Fuda Cancer Hospital, Guangzhou
Shengxin Biotechnology Institute, Beijing · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The aim of this study is the synergistic effect of cancer ablation and life information rehabilitation therapy on unresectable liver cancer.
Timeline
- Start
- 2017-09-02
- Primary completion
- 2018-09-02
- Completion
- 2018-09-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Qilisheng | Unknown | — | Oral |